Licensing
🇺🇸 FDA Page 3FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Unlock global pharma market opportunities. Get expert insights on drug licensing deals, IP strategies, and M&A trends for strategic BD.
Showing 25–36 of 59 articles
Vyome Holdings Q1 2026: FDA Filings and Financial Strength Signal Strategic Momentum
FDA · 10 min
Dr. Sarah MitchellRallybio, Avenzo agree oncology reverse merger backed by $215 million financing
oncology · 8 min
Dr. Sarah MitchellOhioHealth and Fairfield Medical Center Terminate Merger Plans
8 min
Dr. Sarah MitchellServier Acquires Edgewise Therapeutics' Muscular Dystrophy Assets in Potential $2.7 Billion Deal
muscular dystrophy · 13 min
Dr. Sarah MitchellWhite House Taps Amazon, GoodRx to Expand TrumpRx Generic Drug Access
FDA · 7 min
Dr. Sarah MitchellBMS-Hengrui $15B Deal: Strategic Implications for Pharma Executives
FDA · 10 min
Dr. Sarah MitchellLongeveron Stockholder Letter Outlines 2026 Strategy and Partnership Focus
FDA · 6 min
Dr. Sarah MitchellTrumpRx Expands Generic Drug Offerings: Implications for Pharma BD and Investors
FDA · 10 min
Dr. Sarah MitchellEli Lilly's Strategic Vaccine Acquisitions: A New Era in Infectious Disease
FDA · vaccine · 6 min
Dr. Sarah MitchellEli Lilly Acquires Engage Bio to Advance Non-Viral Genetic Medicines
FDA · genetic medicines · 7 min
Dr. Sarah MitchellMerck's ADC Success: Insights from Global Trial Results
FDA · oncology · 8 min
Dr. Sarah MitchellNiowave's $75M Radiopharmaceutical Plant: Industry Implications
FDA · 8 min
Dr. Sarah MitchellExplore intelligence